NBNeha Basheer

Neha Basheer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Neha Basheer has a total of 68 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Micronutrient dynamics and deficiency risk across pregnancy and postpartum in a Slovak cohort

    by Alexandra Kristufkova, Neha Basheer, Katarina Koprdova, Matus Lieskovsky, Michal Fresser, Norbert Zilka

    Objective: To assess the dynamics in blood concentrations of vitamins (A, B6, B12, D, E,), trace elements such as selenium, magnesium, zinc, and iron (transferrin), and metabolite homocysteine during pregnancy and postpartum. Design: Cross-sectional, national cohort study conducted between January and June 2024. Setting: Slovakia. Population: Pregnant and postpartum women. Methods: From venous blood and capillary dry blood spot micronutrients were analysed using standard biochemical and biophysical methods. Main outcome measures: Group differences in blood micronutrient levels across pregnancy and postpartum. Results: Our findings reveal significant differences in maternal micronutrient levels across pregnancy and postpartum. While some nutrients, including vitamin D and folate, remained relatively stable, others such as vitamin A, B12, iron and zinc were observed at lower levels, and vitamin E at higher levels during pregnancy. Vitamin E levels in the 3rd trimester frequently exceeded reference values for the general adult population, whereas zinc levels were significantly lower postpartum. We observed high prevalence of vitamin B12 and iron deficiencies, as indicated by transferrin saturation, particularly in the 3rd trimester. Vitamin D deficiency was prevalent throughout pregnancy and postpartum. Finally, our analysis demonstrated that dried blood spot (DBS) technology provides comparable results to venous blood analysis for measuring vitamin A, D and homocysteine levels.

  • Open Access

    Micronutrient Dynamics and Deficiency Risk Across Pregnancy and Postpartum in a Slovak Cohort

    by Alexandra Kristufkova, Neha Basheer, Katarina Koprdova, Matus Lieskovsky, Michal Fresser, Norbert Zilka

  • Open Access

    Disruption of Extracellular Matrix and Perineuronal Nets Modulates Extracellular Space Volume and Geometry

    by Eva Syková, Ivan Voříšek, Zenon Starčuk, Jiří Kratochvíla, Iveta Pavlova, Yuki Ichikawa, Jessica C. F. Kwok, Eva Kmoníčková, Svitlana Myronchenko, Tomáš Hromádka, et al.

    Extracellular matrix (ECM) is a network of macromolecules which has two forms—perineuronal nets (PNNs) and a diffuse ECM (dECM)—both influence brain development, synapse formation, neuroplasticity, CNS injury and progression of neurodegenerative diseases. ECM remodeling can influence extrasynaptic transmission, mediated by diffusion of neuroactive substances in the extracellular space (ECS). In this study we analyzed how disrupted PNNs and dECM influence brain diffusibility. Two months after oral treatment of rats with 4-methylumbelliferone (4-MU), an inhibitor of hyaluronan (HA) synthesis, we found downregulated staining for PNNs, HA, chondroitin sulfate proteoglycans, and glial fibrillary acidic protein. These changes were enhanced after 4 and 6 months and were reversible after a normal diet. Morphometric analysis further indicated atrophy of astrocytes. Using real-time iontophoretic method dysregulation of ECM resulted in increased ECS volume fractionαin the somatosensory cortex by 35%, fromα = 0.20 in control rats toα = 0.27 after the 4-MU diet. Diffusion-weighted magnetic resonance imaging revealed a decrease of mean diffusivity and fractional anisotropy (FA) in the cortex, hippocampus, thalamus, pallidum, and spinal cord. This study shows the increase in ECS volume, a loss of FA, and changes in astrocytes due to modulation of PNNs and dECM that could affect extrasynaptic transmission, cell-to-cell communication, and neural plasticity.


  • Open Access

    AD-TAU INDUCED TANGLE-LIKE PATHOLOGY IN A NEWLY CHARACTERIZED TRANSGENIC MOUSE MODEL

    by Muhammad Khalid Muhammadi, Tomáš Smolek, Ivana Uhrinova, Neha Basheer, Norbert Zilka

  • Top Cited Papers
    Open Access

    Does modulation of tau hyperphosphorylation represent a reasonable therapeutic strategy for Alzheimer’s disease? From preclinical studies to the clinical trials

    by Neha Basheer, Tomáš Smolek, Imtaiyaz Hassan, Fei Liu, Khalid Iqbal, Norbert Zilka, Petr Novak

    Protein kinases (PKs) have emerged as one of the most intensively investigated drug targets in current pharmacological research, with indications ranging from oncology to neurodegeneration. Tau protein hyperphosphorylation was the first pathological post-translational modification of tau protein described in Alzheimer’s disease (AD), highlighting the role of PKs in neurodegeneration. The therapeutic potential of protein kinase inhibitors (PKIs)) and protein phosphatase 2 A (PP2A) activators in AD has recently been explored in several preclinical and clinical studies with variable outcomes. Where a number of preclinical studies demonstrate a visible reduction in the levels of phospho-tau in transgenic tauopathy models, no reduction in neurofibrillary lesions is observed. Amongst the few PKIs and PP2A activators that progressed to clinical trials, most failed on the efficacy front, with only a few still unconfirmed and potential positive trends. This suggests that robust preclinical and clinical data is needed to unequivocally evaluate their efficacy. To this end, we take a systematic look at the results of preclinical and clinical studies of PKIs and PP2A activators, and the evidence they provide regarding the utility of this approach to evaluate the potential of targeting tau hyperphosphorylation as a disease modifying therapy.


  • Open Access

    Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern

    by Branislav Kovacech, Lubica Fialova, Peter Filipcik, Rostislav Skrabana, Monika Zilkova, Natalia Paulenka-Ivanovova, Andrej Kovac, Denisa Palova, Gabriela Paulikova Rolkova, Katarina Tomkova, et al.